Breaking News Instant updates and real-time market news.

ROKU

Roku

$44.85

1.83 (4.25%)

, XNET

Xunlei

$13.97

1.17 (9.14%)

08:45
02/15/18
02/15
08:45
02/15/18
08:45

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: (ROKU) 23.94% +0.11, Xunlei (XNET) 22.66% +0.10, HanesBrands (HBI) 1.37% +0.08, and GNC Holdings (GNC) 3.19% +0.01.

ROKU

Roku

$44.85

1.83 (4.25%)

XNET

Xunlei

$13.97

1.17 (9.14%)

HBI

Hanesbrands

$21.14

1.21 (6.07%)

GNC

GNC Holdings

$4.18

-0.77 (-15.56%)

  • 21

    Feb

  • 26

    Feb

  • 21

    Mar

ROKU Roku
$44.85

1.83 (4.25%)

02/02/18
NEED
02/02/18
NO CHANGE
Target $50
NEED
Buy
Roku 'shorts should cover' says Needham
Needham analyst Laura Martin keeps her Buy rating and $50 price target on Roku ahead of its Q4 earnings. The analyst says its time for the shorts to cover, with about 7.7M shares short relative to 15M share public float, as the company's strategic position is improving, its competitive moat widening, and its valuation still inexpensive. Martin also believes that the company will likely be added to indices this year, forcing passive money to buy for the first time.
01/09/18
SBSH
01/09/18
NO CHANGE
Target $28
SBSH
Sell
Roku bulls likely hoped for higher account number, says Citi
Citi analyst Mark May says Roku slightly exceeded his 18.7M estimate when announcing last night that it topped 19M active accounts as of December 31, 2017. However, bullish investors that have driven the stock up greater than 100% since the Q3 report are likely hoping for a higher result, May tells investors in a research note. He points out, though, that 19M ending active accounts still represents 43%-45% year-over-year growth, which compares favorably to the 48% growth in Q3 and the 42%-48% growth over the last few quarters. May has a Sell rating on Roku with a $28 price target. The stock in premarket trading is up 1%, or 63c, to $48.10.
01/05/18
01/05/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. PriceSmart (PSMT) downgraded to Sector Perform from Outperform at Scotia Howard Weil. 2. Teva (TEVA) downgraded to Underperform from Market Perform at Wells Fargo with analyst David Maris saying Teva shares have now risen approximately 80% from its lows in November. 3. Roku (ROKU) downgraded to Sell from Neutral at Citi with analyst Mark May saying the stock is up 266% from its initial public offering price of $14 just three months ago. 4. Johnson Controls (JCI) downgraded to Neutral from Outperform at Baird with analyst Timothy Wojs saying valuation is fair in light of slower growth, lower free-cash flow conversion, and "choppier" execution. 5. Wingstop (WING) downgraded to Neutral from Outperform at Wedbush with analyst Nick Setyan saying while drivers of "solid" low single-digit same-store sales growth in 2018 exist, current consensus estimates may prove "overly optimistic." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/05/18
SBSH
01/05/18
NO CHANGE
Target $1400
SBSH
Buy
Citi names Amazon top Internet pick for 2018, ups target to $1,400
Citi analyst Mark May remains bullish on the consumer Internet sector, especially over the near term. The analyst believes a "positive, tax reform fueled, business climate" should benefit the end-markets of the companies in the space. After outperformance in 2017, however, he recommends being more selective in 2018. Amazon.com (AMZN) moves up a spot to become his top-ranked pick for 2018. May sees the combination of greater than 30% sales growth, margin expansion and the current valuation as a "compelling mix." He raised his price target for Amazon shares to $1,400 from $1,250. May's most- to least-favored stocks under coverage, in order, are: Amazon, Expedia (EXPE), Facebook (FB), Priceline (PCLN), Alphabet (GOOGL), eBay (EBAY), Yelp (YELP), Twitter (TWTR), TripAdvisor (TRIP), Netflix (NFLX), GrubHub (GRUB), GoDaddy (GDDY), Despegar.com (DESP), trivago (TRVG), LendingClub (LC), Wayfair (W), Snap (SNAP), Zillow (ZG), Blue Apron (APRN) and Roku (ROKU), which he downgraded this morning to Sell.
XNET Xunlei
$13.97

1.17 (9.14%)

HBI Hanesbrands
$21.14

1.21 (6.07%)

12/19/17
SBSH
12/19/17
DOWNGRADE
Target $23
SBSH
Neutral
Hanesbrands downgraded to Neutral from Buy at Citi
Citi analyst Kate McShane downgraded Hanesbrands to Neutral saying the U.S. wholesale environment remains challenging due to declining traffic trends in stores and price-based competition in all channels. The analyst does not believe Hanesbrands can fully recoup the loss of sales in-store via online channels. As such, she's less bullish on the company's 2018 prospects and cut her price target for the shares to $23 from $29.
12/19/17
12/19/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Neutral from Buy at Nomura Instinet with analyst Jeffrey Kvaal saying the stock's gains for the iPhone X "supercycle are in the late innings." 2. Hanesbrands (HBI) downgraded to Neutral from Buy at Citi with analyst Kate McShane saying the U.S. wholesale environment remains challenging due to declining traffic trends in stores and price-based competition in all channels. 3. PPL Corp. (PPL) downgraded to Underperform from Neutral at Macquarie with analyst Angie Storozynski saying she thinks the next UK regulatory review will result in a meaningful drop in revenues and believes the high dividend debate will come back into focus. 4. Chubb (CB) downgraded to Neutral from Outperform at Credit Suisse with analyst Ryan Tunis noting that while the integration of ACE Limited (ACE)/Chubb has been successful and positions the latter well for the future, the analyst argues that it is difficult for him to solve for much upside to medium term earnings per share and shares with the integration coming to a close in the fourth quarter. 5. KB Home (KBH) downgraded to Underweight from Neutral at JPMorgan with analyst Michael Rehaut citing valuation with the shares up 100% in 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/19/18
DADA
01/19/18
NO CHANGE
Target $47
DADA
Buy
Columbia Sportswear to benefit from easy SSS and cold weather, says DA Davidson
DA Davidson analyst Andrew Burns previews Q4 earnings for Apparel & Footwear, suggesting that consensus estimates may be attainable and possibly beatable. The analyst notes that last year's underperformance sets up easy comps, while better than expected holiday season and cold winter weather will allow companies to exceed expectations. Burns prefers Columbia Sportswear (COLM) and Hanesbrands (HBI) in the space, keeping a Buy rating on both companies.
02/09/18
DADA
02/09/18
NO CHANGE
Target $27
DADA
Buy
Hanesbrands price target lowered to $27 from $31 at DA Davidson
DA Davidson analyst Andrew Burns lowered his price target on Hanesbrands to $27 after in-line Q4 results, but sees the latest sell-off in the stock price as overdone based on the company's "undervalued brand portfolio with leading market share, mid-teens margins and strong cash flow". Burns keeps his Buy rating on Hanesbrands.
GNC GNC Holdings
$4.18

-0.77 (-15.56%)

01/31/18
DBAB
01/31/18
NO CHANGE
DBAB
Amazon remains low-price leader in supplements, says Deutsche Bank
Deutsche Bank analyst Shane Higgins conducted an online pricing study comparing 80 identical third-party online vitamin and supplement products at GNC Holdings (GNC), Vitamin Shoppe (VSI), Amazon (AMZN) and Bodybuilding.com. The study found that Amazon "easily expanded" its price advantage against each of the other three retailers, Higgins tells investors in a research note. Among the specialty players, Vitamin Shoppe slightly improved its price advantage versus GNC, the analyst adds. He expects Amazon to keep pressure on the specialty players, particularly as its Prime membership grows.
01/18/18
BOFA
01/18/18
NO CHANGE
Target $2.5
BOFA
Underperform
GNC Holdings options remain limited, says BofA/Merrill
BofA/Merrill analyst Curtis Nagle reiterated his Underperform rating and $2.50 price target on GNC Holdings saying he is skeptical that a turnaround under the One GNC strategy will lead to sustainable profitable growth. Nagle said GNC is lapping substantial price cuts this year that will make comp and gross margin growth difficult, and believes the company will have difficulty refinancing its $1.1B term loan without doing so at stiff rate.
04/19/17
JPMS
04/19/17
NO CHANGE
Target $12
JPMS
Neutral
GNC Holdings price target raised to $12 from $10 at JPMorgan
JPMorgan analyst Christopher Horvers raised his price target for GNC Holdings to $12 saying yesterday's earnings and comp beat "take off the table the terminal value question that many investors were focused on." The question, however, is if the traffic is sustainable and whether GNC can turn the decline in average ticket up, Horvers tells investors in a post-earnings research note. The analyst keeps a Neutral rating on the shares.

TODAY'S FREE FLY STORIES

SVMK

SurveyMonkey

$15.38

0.2 (1.32%)

11:42
03/20/19
03/20
11:42
03/20/19
11:42
Conference/Events
SurveyMonkey management to meet with Suntrust »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

ORCL

Oracle

$53.54

-0.5 (-0.93%)

11:40
03/20/19
03/20
11:40
03/20/19
11:40
Downgrade
Oracle rating change  »

Oracle downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELOX

Eloxx Pharmaceuticals

$12.90

-0.26 (-1.98%)

11:40
03/20/19
03/20
11:40
03/20/19
11:40
Conference/Events
Eloxx Pharmaceuticals management to meet with Suntrust »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 27

    Mar

TWTR

Twitter

$32.33

1.05 (3.36%)

11:40
03/20/19
03/20
11:40
03/20/19
11:40
Options
Flurry of activity in Twitter calls as shares see relative strength »

Flurry of activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 23

    Apr

CCOI

Cogent

$51.08

-0.46 (-0.89%)

11:39
03/20/19
03/20
11:39
03/20/19
11:39
Conference/Events
Cogent management to meet with Suntrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

PLPRF

Plus Products

$0.00

(0.00%)

11:38
03/20/19
03/20
11:38
03/20/19
11:38
Initiation
Plus Products initiated  »

Canaccord starts legal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WYND

Wyndham Destinations

$41.14

-0.145 (-0.35%)

11:38
03/20/19
03/20
11:38
03/20/19
11:38
Conference/Events
Wyndham Destinations management to meet with Suntrust »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

CX

Cemex

$4.85

-0.04 (-0.82%)

11:31
03/20/19
03/20
11:31
03/20/19
11:31
Hot Stocks
Cemex reaches agreement to divest white cement business for approx. $180M »

CEMEX announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

CONE

CyrusOne

$51.65

-0.06 (-0.12%)

11:30
03/20/19
03/20
11:30
03/20/19
11:30
Conference/Events
CyrusOne management to meet with Suntrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 18

    Jun

VALE

Vale

$13.55

-0.15 (-1.09%)

11:30
03/20/19
03/20
11:30
03/20/19
11:30
Options
Delta neutral downside put block crossed firm to firm in Vale »

Delta neutral downside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

AMED

Amedisys

$124.56

-1.96 (-1.55%)

11:29
03/20/19
03/20
11:29
03/20/19
11:29
Conference/Events
Amedisys management to meet with Suntrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    Mar

  • 29

    Mar

  • 02

    Apr

  • 03

    Apr

OBSV

ObsEva

$12.90

-0.07 (-0.54%)

11:26
03/20/19
03/20
11:26
03/20/19
11:26
Conference/Events
ObsEva management to meet with JPMorgan »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 27

    Mar

11:25
03/20/19
03/20
11:25
03/20/19
11:25
General news
Euro$ interest rate futures backed up »

Euro$ interest rate…

11:25
03/20/19
03/20
11:25
03/20/19
11:25
Conference/Events
JPMorgan SMid Cap biotech analyst to hold a group luncheon »

SMid-Cap Biotech Analysts…

DB

Deutsche Bank

$8.92

-0.125 (-1.38%)

11:20
03/20/19
03/20
11:20
03/20/19
11:20
Options
Defensive option play opened in Deutsche Bank »

Defensive option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$324.35

0.81 (0.25%)

, NITE

Nightstar Therapeutics

$25.35

0.075 (0.30%)

11:19
03/20/19
03/20
11:19
03/20/19
11:19
Recommendations
Biogen, Nightstar Therapeutics analyst commentary at Mizuho »

Biogen likely not done…

BIIB

Biogen

$324.35

0.81 (0.25%)

NITE

Nightstar Therapeutics

$25.35

0.075 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 24

    Apr

  • 30

    Apr

  • 01

    May

  • 28

    May

FB

Facebook

$163.54

1.95 (1.21%)

11:19
03/20/19
03/20
11:19
03/20/19
11:19
Hot Stocks
Facebook announces Oculus Rift S launching Spring 2019 »

At Game Developers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 03

    Apr

  • 04

    Apr

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
03/20/19
03/20
11:17
03/20/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:16
03/20/19
03/20
11:16
03/20/19
11:16
Conference/Events
JPMorgan air/surface transport analyst to hold analyst/industry conference call »

Airfreight & Surface…

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
03/20/19
03/20
11:16
03/20/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URI

United Rentals

$115.84

-4.79 (-3.97%)

11:15
03/20/19
03/20
11:15
03/20/19
11:15
Options
United Rentals put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:12
03/20/19
03/20
11:12
03/20/19
11:12
Conference/Events
JPMorgan healthcare tech analyst to hold an analyst/industry conference call »

Healthcare Technology…

CGC

Canopy Growth

$47.83

1.75 (3.80%)

11:05
03/20/19
03/20
11:05
03/20/19
11:05
Options
Canopy Growth call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$8.51

-0.195 (-2.24%)

11:03
03/20/19
03/20
11:03
03/20/19
11:03
Hot Stocks
Ford to invest over $850M to expand EV production capacity at Michigan plant »

Ford announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

CMTL

Comtech

$21.65

-0.33 (-1.50%)

11:01
03/20/19
03/20
11:01
03/20/19
11:01
Hot Stocks
Comtech receives $2.2M contract for Midia gas development project in Romania »

Comtech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.